Novo Nordisk India has cut prices of its blockbuster weight-loss and diabetes medications, as an onset of cheaper generic drugs raises competition for the Danish drugmaker in the world’s third most overweight country https://www.bloomberg.com/news/articles/2026-03-31/novo-nordisk-india-cuts-prices-of-weight-loss-diabetes-drugs?taid=69cbbeeece3e6b00011e370f&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter